These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1283721)

  • 21. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
    Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
    Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic inhibition of HIV-1 envelope-mediated cell fusion by CD4-based molecules in combination with antibodies to gp120 or gp41.
    Allaway GP; Ryder AM; Beaudry GA; Maddon PJ
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):581-7. PubMed ID: 8369162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.
    Jiang SB; Lin K; Neurath AR
    J Exp Med; 1991 Dec; 174(6):1557-63. PubMed ID: 1836013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD4-imitating human antibodies in HIV infection and anti-idiotypic vaccination.
    Deckert PM; Ballmaier M; Lang S; Deicher H; Schedel I
    J Immunol; 1996 Jan; 156(2):826-33. PubMed ID: 8543839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog.
    Nishiyama Y; Mitsuda Y; Taguchi H; Planque S; Salas M; Hanson CV; Paul S
    J Biol Chem; 2007 Oct; 282(43):31250-6. PubMed ID: 17728243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The envelope glycoprotein of HIV-1 gp120 and human complement protein C1q bind to the same peptides derived from three different regions of gp41, the transmembrane glycoprotein of HIV-1, and share antigenic homology.
    Stoiber H; Thielens NM; Ebenbichler C; Arlaud GJ; Dierich MP
    Eur J Immunol; 1994 Feb; 24(2):294-300. PubMed ID: 7507842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunizations of monkeys with synthetic peptides disclose conserved areas on gp120 of human immunodeficiency virus type 1 associated with cross-neutralizing antibodies and T-cell recognition.
    Vahlne A; Horal P; Eriksson K; Jeansson S; Rymo L; Hedström KG; Czerkinsky C; Holmgren J; Svennerholm B
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10744-8. PubMed ID: 1961741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.
    Zvi A; Feigelson DJ; Hayek Y; Anglister J
    Biochemistry; 1997 Jul; 36(28):8619-27. PubMed ID: 9214308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic peptides from a conserved region of gp120 induce broadly reactive anti-HIV responses.
    Morrow WJ; Williams WM; Whalley AS; Ryskamp T; Newman R; Kang CY; Chamat S; Köhler H; Kieber-Emmons T
    Immunology; 1992 Apr; 75(4):557-64. PubMed ID: 1592430
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for epitope-specific antibody responses to the human immunodeficiency virus (HIV-1) envelope glycoproteins signifying resistance to disease development.
    Neurath AR; Strick N; Taylor P; Rubinstein P; Stevens CE
    AIDS Res Hum Retroviruses; 1990 Oct; 6(10):1183-92. PubMed ID: 1701315
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.
    Haynes BF; Torres JV; Langlois AJ; Bolognesi DP; Gardner MB; Palker TJ; Scearce RM; Jones DM; Moody MA; McDanal C
    J Immunol; 1993 Aug; 151(3):1646-53. PubMed ID: 8335949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-idiotypic antibodies to human anti-gp120 antibodies bind recombinant and cellular human CD4.
    Corre JP; Février M; Chamaret S; Thèze J; Zouali M
    Eur J Immunol; 1991 Mar; 21(3):743-51. PubMed ID: 1672646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal antibodies to gp120 V3 sequence do not correlate with protection against vertical transmission of human immunodeficiency virus.
    Robertson CA; Mok JY; Froebel KS; Simmonds P; Burns SM; Marsden HS; Graham S
    J Infect Dis; 1992 Oct; 166(4):704-9. PubMed ID: 1527406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120.
    Ardman B; Kowalski M; Bristol J; Haseltine W; Sodroski J
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):206-14. PubMed ID: 2304000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Broad HIV-1 neutralization mediated by CD4-binding site antibodies.
    Li Y; Migueles SA; Welcher B; Svehla K; Phogat A; Louder MK; Wu X; Shaw GM; Connors M; Wyatt RT; Mascola JR
    Nat Med; 2007 Sep; 13(9):1032-4. PubMed ID: 17721546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY; Hariharan K; Posner MR; Nara P
    J Immunol; 1993 Jul; 151(1):449-57. PubMed ID: 7686944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.